Volume 27, Number 7—July 2021
Research
Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June–October 2020
Table
Clinical specimens | Symptom onset | Collection date | RT-PCR SARS-CoV-2 | RT-PCR SARS-CoV-2 (LVRS, Fiocruz) | Sequencing GISAID clade/PANGO lineage | Antigen test (Abbott) | IgG | Neutralization assay |
---|---|---|---|---|---|---|---|---|
NPS, sample 1 |
2020 Jun 17 |
2020 Jun 23 |
Positive, Ct E = 22, Ct RP = 21 (LACEN-PB) |
Positive, Ct E = 24, Ct N1 = 24, Ct N2 = 25, Ct RP = 26 |
GR/B.1.1.33 |
Positive |
NA |
NA |
NPS, sample 2 |
Asymptomatic |
2020 Sep 8 |
ND, Ct E = ND, Ct RP = 25 (UFRN) |
NA |
NA |
NA |
NA |
NA |
NPS, sample 3 |
2020 Oct 11 |
2020 Oct 13 |
Positive, Ct E = 25, Ct RP = 24 (LACEN-PB) |
Positive, Ct E = 22, Ct N1 = 23, Ct N2 = 22, Ct RP = 26 |
GR/P.2 |
Positive |
NA |
NA |
Serum specimen, sample 4 | NA | 2020 Dec 13 | NA | NA | NA | NA | Positive | B.1<10, P.1<10, P.2<10, B.1.1.7<10 |
*CPE, cytopathic effect; Ct, cycle threshold; E, envelope protein; LACEN-PB, Laboratório Central do Estado da Paraíba; LVRS, Respiratory Virus and Measles Laboratory; N1 and N2, portion of nucleoprotein; NA, not applicable; ND, not detected; NPS, nasopharyngeal swab specimen; PANGO, Phylogenetic Assignment of Named Global Outbreak Lineages; RP, human RNase P gene; RT-PCR, reverse transcription PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UFRN, Federal University of Rio Grande do Norte.
1These authors share senior authorship.
Page created: April 12, 2021
Page updated: June 16, 2021
Page reviewed: June 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.